Tech Company Financing Transactions

Igenica Funding Round

5AM Ventures, OrbiMed and The Column Group participated in a $24 million Series B funding round for Igenica. The round closed on 6/11/2010.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

863 Mitten Rd. 102
Burlingame, CA 94010
USA

Phone

(650) 231-4320

Website

www.igenica.com

Email Address

[email protected]

Overview

Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Financial Officer

Hans van Houte

        

VP - Bus. Development

John Celebi

        

Browse more venture capital transactions:

Prev: 6/11/2010: Otonomy venture capital transaction
Next: 6/11/2010: Castlight Health venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary